Organization Overview
Alternative names
amoxicillin (2019)
naloxegol (movantik) (2014)
omeprazole (prilosec) (2019)
rifabutin (mycobutin) (2019)
rifamycin (aemcolo) (2018)
Bronchiectasis (Phase 3)
Carcinoma (Phase 2)
Carcinoma, Hepatocellular (Phase 2)
Cholangiocarcinoma (Phase 2)
Coronavirus Infections (Phase 2)
Crohn Disease (Phase 3)
Diarrhea (Phase 2)
Dyspepsia (Phase 3)
Gastritis (Phase 3)
Gastroenteritis (Phase 3)
Infections (Phase 3)
Irritable Bowel Syndrome (Phase 2)
Klatskin Tumor (Phase 2)
Lung Diseases (Phase 3)
Lymphoma (Phase 2)
Lymphoma, B-Cell (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 2)
Multiple Myeloma (Phase 2)
Multiple Sclerosis (Phase 2)
Multiple Sclerosis, Relapsing-Remitting (Phase 2)
Mycobacterium Infections (Phase 3)
Neoplasms, Plasma Cell (Phase 2)
Paratuberculosis (Phase 3)
Pneumonia (Phase 3)
Sarcoma (Phase 2)
Sarcoma, Kaposi (Phase 2)
Sclerosis (Phase 2)
Severe Acute Respiratory Syndrome (Phase 2)
Syndrome (Phase 2)
Vomiting (Phase 3)